India may get it’s Covid vaccine by the end of January

India may get it’s Covid vaccine by the end of January and approximately upto end of October normal life would begin.

SII chief has confidence in his vaccine and in his interviews promised  India that they would soon provide the vaccine.

Serum Institute of India (SII) chief executive Adar Poonawalla said the Covid-19 vaccination program could start in India in January as his company - which also tests and manufactures Oxford-AstraZeneca - was expecting to get emergency use certification by the end of the month.

Speaking at The Economic Times Global Business Summit, Adar Poonawalla said he expected everyone in India to be vaccinated before October 2021 following a normal life that could return.“At the end of the month, we may be able to get an emergency license [for coronavirus vaccine], but a real wide-ranging license may apply later. But we are confident that if the regulators agree, the India vaccination program could begin in January 2021, "Adar Poonawalla said.

"If 20% of Indians get the coronavirus vaccine, I hope we can see the confidence and feelings return, and by September to October next year I hope there will be enough injections for everyone and normal health can return," said the SII chief. Last week, the Sub-Committee of Experts (SEC), which is considering applications from three companies for authorization for emergency use of their Covid-19 drugs in India, asked Serum Institute of India (SII) and Bharat Biotech for additional safety delays and performance data report from their ongoing testing.

The interim results of the Oxford Covid-19 vaccine trial, published in The Lancet, show that the vaccine protects against symptomatic disease in 70 percent of cases, with vaccines effective in 62 percent of those given two full doses, and 90 percent of those given half, and then the full dose.

The Oxford vaccine uses the chimpanzee adenovirus vector which cannot cause infections in humans and produce the SARS-CoV-2 spike protein spike. This means that the vaccine introduces spike protein genetic code into vaccinated human cells, protein production starts, and further teaches the immune system to recognize and attack the virus.